Silencing AXL by covalent siRNA-gelatin-antibody nanoconjugate inactivates mTOR/EMT pathway and stimulates p53 for TKI sensitization in NSCLC

Autor: Suresh, Dhananjay, Zambre, Ajit, Mukherjee, Soumavo, Ghoshdastidar, Shreya, Jiang, Yuexu, Joshi, Trupti, Upendran, Anandhi, Kannan, Raghuraman
Zdroj: In Nanomedicine: Nanotechnology, Biology, and Medicine August 2019 20
Databáze: ScienceDirect